Accueil › Cancer de l'estomac › Texas › San Antonio
Essais cliniques pour Cancer de l'estomac à San Antonio, TX
19 études pour Cancer de l'estomac recherchent des participants dans et autour de San Antonio (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Audie L Murphy VA Hospital, San Antonio
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Recrutement en coursPhase 2/3
- Texas Oncology - San Antonio, San Antonio
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology - PARENT, San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Recrutement en coursPhase 1/2
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Recrutement en coursPhase 1/2
- START South Texas Accelerated Research Therapeutics, San Antonio
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1
- NEXT Oncology, San Antonio
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Recrutement en coursPhase 1
- START - San Antonio, San Antonio
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Recrutement en coursPhase 1/2
- South Texas Accelerated Research Therapeutics (START), LLC, San Antonio
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Recrutement en coursPhase 1
- NEXT San Antonio, San Antonio
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- Research Site, San Antonio
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- UT Health Mays Cancer Center, San Antonio
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- Clinical Trial Site, San Antonio
IDOV-Immune for Advanced Solid Tumors
Recrutement en coursPhase 1
- South Texas Accelerated Research Therapeutics, San Antonio
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Recrutement en coursPhase 1
- NEXT Virginia, LLC, San Antonio
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Recrutement en coursPhase 1
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1
- START San Antonio, LLC., San Antonio
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Recrutement en coursPhase 1
- NEXT Oncology /ID# 243007, San Antonio
- South Texas Accelerated Research Therapeutics (START) /ID# 276268, San Antonio
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- NEXT Oncology, San Antonio
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Recrutement en coursPhase 1
- Dren Investigational Site, San Antonio
Essais pour Cancer de l'estomac dans d'autres villes
- Houston, TX42 études
- Boston, MA32 études
- New York City, NY31 études
- Nashville, TN28 études
- Baldwin Park, CA22 études
- Los Angeles, CA22 études
- Arlington, VA20 études
- Dallas, TX19 études
- St. Louis, MO18 études
- Grand Rapids, MI18 études
- Washington, DC16 études
- Chicago, IL16 études
Autres études à San Antonio
- Cancer du poumon non à petites cellules59 études
- Cancer du sein47 études
- Cancer colorectal46 études
- Cancer métastatique44 études
- Cancer (tous types)41 études
- Obésité40 études
- Diabète de type 237 études
- Surpoids34 études
- Cancer de l'ovaire31 études
- Cancer du pancréas31 études
- Cancer de la prostate28 études
- Cancer de l'endomètre27 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.